BackgroundCheck.run
Search For

Thomas Ele Yorio, 76208 Briar Haven Ct, Burleson, TX 76028

Thomas Yorio Phones & Addresses

208 Briar Haven Ct, Burleson, TX 76028    817-2951593    817-2956244   

2112 Portofino Dr, Rockwall, TX 75032    972-7223568    972-7224451   

500 Throckmorton St, Fort Worth, TX 76102   

Fall River Mills, CA   

Bronx, NY   

208 Briar Haven Ct, Burleson, TX 76028   

Work

Position: Private Household Service Occupations

Education

Degree: Associate degree or higher

Mentions for Thomas Ele Yorio

Publications & IP owners

Us Patents

Endothelin Antagonists And Endothelin-Converting Enzyme Inhibitors For The Treatment Of Glaucoma

US Patent:
2003017, Sep 18, 2003
Filed:
Apr 24, 2002
Appl. No.:
10/131787
Inventors:
Thomas Yorio - Burleson TX, US
Ganesh Prasanna - Fort Worth TX, US
Adnan Dibas - Fort Worth TX, US
Martha Stokely - Fort Worth TX, US
Assignee:
University of North Texas Health Science Center - Fort Worth TX
International Classification:
A61K038/08
A61K031/519
US Classification:
514/017000, 514/259100
Abstract:
A pharmaceutical composition, containing a therapeutically effective amount of an endothelin (“ET”) antagonists and/or an endothelin-converting enzyme (“ECE”) inhibitors and a pharmaceutically acceptable carrier. The pharmaceutical composition is useful for treating normal-tension and primary open-angle glaucoma and prevents optic nerve damage and retinal ganglion cell death associated with these ocular diseases.

Phenanthroline And Derivatives Thereof Used To Lower Intraocular Pressure In An Affected Eye

US Patent:
2006011, May 25, 2006
Filed:
Nov 18, 2005
Appl. No.:
11/282277
Inventors:
Adnan Dibas - Arlington TX, US
Thomas Yorio - Burleson TX, US
Ganesh Prasanna - San Diego CA, US
Assignee:
University of North Texas Health Science Center at Fort Worth - Fort Worth TX
International Classification:
A61K 31/4745
A61K 31/5377
A61K 31/557
A61K 31/4178
A61K 31/137
US Classification:
514292000, 514232500, 514573000, 514397000, 514649000
Abstract:
Methods and compositions used for lowering intraocular pressure. More particularly, the methods and compositions for lowering intraocular pressure pertain to the use of at least a phenanthroline derivative in an ophthalmic delivery solution.

Compositions And Their Use In Lowering Intraocular Pressure

US Patent:
5304569, Apr 19, 1994
Filed:
Oct 31, 1990
Appl. No.:
7/607398
Inventors:
Risto Lammintausta - Turku, FI
Arto Karjalainen - Oulu, FI
Ewen MacDonald - Kuopio, FI
Arto Urtti - Kuopio, FI
Raimo Virtanen - Rusko, FI
Thomas Yorio - Burleson TX
Assignee:
Orion-yhtyma Oy - Espoo
International Classification:
A61K 31415
US Classification:
514396
Abstract:
Compounds of formula: ##STR1## where X is --CH. sub. 2 --, --CH(CH. sub. 3)--, --CHR. sub. 3 --CH. sub. 2 -- or --CR. sub. 3. dbd. CH-- and R. sub. 1, R. sub. 2 and R. sub. 3, which can be the same or different, are each H or CH. sub. 3 or a stereoisomer or pharmaceutically acceptable salt thereof, and pharmaceutical compositions containing them, are useful for lowering intraocular pressure in a mammal, e. g. in the treatment of glaucoma.

Isbn (Books And Publications)

Ocular Therapeutics: Eye On New Discoveries

Author:
Thomas Yorio
ISBN #:
0123705851

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.